Ethyl dirazepate
Appearance
![]() | |
Identifiers | |
---|---|
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
ChEMBL | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C18H14Cl2N2O3 |
Molar mass | 377.22 g·mol−1 |
3D model (JSmol) | |
| |
| |
![]() ![]() |
Ethyl dirazepate[1] is a drug which is a benzodiazepine derivative[2] which was developed by Sanofi Winthrop. It has anxiolytic and hypnotic and possibly other characteristic benzodiazepine properties.[3][4][5]
See also
[edit]References
[edit]- ^ ZA Patent 6804601
- ^ Zaman H, Sampson SJ, Beck AL, Sharma T, Clay FJ, Spyridi S, et al. (December 2017). "Benzodiazepines for psychosis-induced aggression or agitation". The Cochrane Database of Systematic Reviews. 12 (12): CD003079. doi:10.1002/14651858.CD003079.pub4. PMC 6486117. PMID 29219171.
- ^ "ethyl dirazepate". psychotropics.dk. 2003. Retrieved 7 December 2009.
- ^ "Drugs of the Future". Thomson Reuters. 6 (11). November 1981.
- ^ "LIST OF INTERNATIONAL NON-PROPRIETARY NAMES (INNS), PROVIDED FOR PHARMACEUTICAL SUBSTANCES BY THE WORLD HEALTH ORGANIZATION, WHICH ARE FREE OF DUTY". Official Journal of the European Communities. eur-lex.europa.eu. 23 October 2001. Archived from the original (PDF) on 27 June 2014. Retrieved 7 December 2009.